Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation.
Chen YL, Zhuo R, Sun LC, Tao YF, Li G, Zhu F, Xu YY, Wang JW, Li ZH, Yu JJ, Yin HL, Wu D, Li XL, Fang F, Xie Y, Hu YZ, Wang HR, Yang C, Shi L, Wang XD, Zhang ZM, Pan J.
Chen YL, et al.
Neuro Oncol. 2024 Jun 12:noae109. doi: 10.1093/neuonc/noae109. Online ahead of print.
Neuro Oncol. 2024.
PMID: 38864832